MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Dopamine agonist use and psychotic symptoms in patients with Parkinson’s disease.

    D. Ortiz-Zacarias, S. Castillo-Torres, M. Cansino-Torres, J. Trejo-Ayala, B. Chávez-Luevanos, I. Estrada-Bellmann (Monterrey, Mexico)

    Objective: To describe the clinical and demographic characteristics of patients with PDP and their relationship with the use of DAs. Background: Parkinson’s Disease Psychosis (PDP)…
  • 2024 International Congress

    The Neuroprotective Effects of Rolipram, a Selective Phosphodiesterase IV Inhibitor, on Parkinson’s Disease in Rat Models: A Pharmacological Exploration in both In vivo and In vitro Settings

    R. Kumar, A. Kanojia (Darbhanga, India)

    Objective: Our research sought to unravel the pharmacological effects and mechanisms of action of Rolipram through both in vivo and in vitro experimentation in models…
  • 2024 International Congress

    Comorbid Tardive Dyskinesia (TD) and Restless Leg Syndrome (RLS)

    V. Chang, T. Stiep (San Francisco, USA)

    Objective: To describe an unusual co-occurrence of disorders involving dopaminergic dysregulation. Background: TD and RLS result from opposing abnormalities in dopaminergic transmission pathways in the…
  • 2024 International Congress

    Systematic Review of Incidence and Prevalence Studies of Multiple System Atrophy

    B. Benzahia, E. Carter, D. Swallow (Aberdeen, United Kingdom)

    Objective: This study sought to systematically review the methods and results of previous incidence and prevalence studies of MSA. Background: High-quality incidence and prevalence studies…
  • 2024 International Congress

    Clinical characteristics of movement disorders associated with multiple sclerosis patients: A cross sectional preliminary single center results.

    MM. Meshref, AF. El-Adawy, FM. Mansour, MH. Moawad, MEL. Elmasry, HG. Gad (Cairo, Egypt)

    Objective: The aim of our study was to observe the clinical characteristics of different movement disorders (MD) in patients with multiple sclerosis (MS). Background: Demyelinating…
  • 2024 International Congress

    Reliability and Validity of the English Version of the Parkinson Anxiety Scale

    J. Lam, X. Tang, D. Meng, P. Uzelman, F. Pio, N. Ainsworth, F. Vila-Rodriguez, S. Appel-Cresswell (Vancouver, Canada)

    Objective: To evaluate the reliability and validity of the English version of the Parkinson Anxiety Scale (PAS) in patients with Parkinson’s disease (PD). Background: The…
  • 2024 International Congress

    Pump Priming a Parkinson’s Rapid Response Physiotherapy and Occupational Therapy Service

    F. Lindop, R. Skelly, B. Denney, S. Voyce (Derby, United Kingdom)

    Objective: To establish a Parkinson's (PD) rapid therapy service offering in-reach to wards and outreach into the community. The aim is to improve overall care,…
  • 2024 International Congress

    Revitalizing Lives: The Dystonia Care Rehabilitation Program

    A. Zawar (Lynnwood, USA)

    Objective: The Cervical Dystonia Care Program aims to enhance engagement in task-specific performance, improve quality of life, activity tolerance, and facilitate a return to higher…
  • 2024 International Congress

    Effects of Telerehabilitation on Balance, Gait, Functional Mobility, Physical Activity, Quality of Life, and Social Support Among Adults with Parkinson Disease: A Systematic Review

    P. Darbandsari, L. Pescatello, D. Piscitelli, J. Smith, C. Colon-Semenza (Storrs, USA)

    Objective: This systematic review examined the effect of telerehabilitation on balance, gait, functional mobility, physical activity, quality of life, and social support among adults living…
  • 2024 International Congress

    Impact of Community Boxing Program on Non-motor Symptoms in Individuals with Parkinson’s Disease

    M. Braitsch, S. Shearin, R. Querry, E. Perez (Richardson, USA)

    Objective: The purpose of this intervention was to assess the impact of boxing on non-motor symptoms (NMS) in PD. Background: ​​​​​​For persons with Parkinson’s Disease…
  • « Previous Page
  • 1
  • …
  • 60
  • 61
  • 62
  • 63
  • 64
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley